| Availability: | |
|---|---|
INCI Name | Acetyl Hexapeptide‑8, Water, Caprylyl Glycol |
Colour | Colorless |
Appearance | Transparent solution |
Peptide Content | ≥450 ppm |
pH | 3.0–6.0 |
Recommended Dosage | 3%–10% |
Compatibility | Avoid compounds containing aldehydes, ketones, metal ions, strong acids, strong bases, and active enzymes. |
Scientific Mechanism & Safety Profile
Acetyl Hexapeptide‑8 operates through a well‑established molecular mechanism: it competes for a position within the SNARE complex, preventing the fusion of synaptic vesicles with the presynaptic membrane and thus attenuating the exocytosis of acetylcholine. This reduces the intensity of muscle contractions that repeatedly crease the skin, effectively diminishing dynamic wrinkles over time. The peptide is not listed as a restricted substance in the EU or U.S., and the Cosmetic Ingredient Review (CIR) Expert Panel has concluded it is safe under current practices of use. Toxicological tests confirm zero toxicity; in‑vitro assays show no irritation, and Human Repeat Insult Patch Test (HRIPT) results demonstrate no skin sensitization response.
In a 30‑day clinical study, 10 volunteers applied a cream containing 50 ppm Acetyl Hexapeptide‑8 twice daily; wrinkle depth measured via standardized replicas showed a 30% reduction compared to control. In another trial, a 38‑year‑old subject used an O/W emulsion with 10% Acetyl Hexapeptide‑8; silicone imprints analyzed by confocal microscopy at day 15 and day 30 revealed visible, progressive reduction in wrinkle depth and surface topography. These data confirm that WKPep®Argine500 Plus delivers rapid, visible smoothing of expression lines with a robust safety margin, making it an ideal active for anti‑aging serums, eye creams, and facial masks targeting dynamic wrinkles.